Recipe List

Strangvac suspension for inj 8 x 1 dose

Descargo de responsabilidad: el producto de la foto puede diferir del producto real.

SKU
DE043804
Marca:
Dechra
Batch:
LT23015
Expiry date:
31-05-2024
Número de registro:
NL: REG NL 126414

Is the registration number of your country not listed? Then this product falls within the cascade control system. For more information, click here (please check the rules of your country, they may deviate).

Disponible a pedido

Strangvac suspension for inj 8 x 1 dose 

Strangvac is a vaccine that is administered to horses from the age of 8 months to alleviate the clinical signs of the acute stage of strangles. Strangles is an infection of the upper respiratory tract and regional lymph nodes of horses caused by the bacterium Streptococcus equi.

The vaccine is composed of recombinant proteins of Streptococcus equi and is administered to horses with an increased risk of infection. The onset of immunity is from two weeks after second vaccination, the duration of immunity is 2 months after the second vaccination and an immunological memory response lasts for 6 months.

 

  • Ready to use
  • IM (nog longer needs to be injected into the lip)
  • DIVA-Vaccins
  • Tackles most strains worldwide

One pack contains 8 x 1 dose.

Indicaciones de uso

Before use, shake well.
Primary vaccination course: one dose (2 ml) intramuscularly, second dose (2 ml) four weeks after the first.
Revaccination: in horses with increased risk of infection, repeat primary vaccination course after two months.

Recombinant protein CCE from Streptococcus equi ≥ 111.8 micrograms*
Recombinant protein Eq85 from Streptococcus equi ≥ 44.6 micrograms*
Recombinant protein IdeE from Streptococcus equi ≥ 34,6 micrograms*

Consejos veterinarios

Reduces signs of disease in the acute stage, vaccinated horses can still get infected and secrete Streptococcus equi. Precautions remain necessary to prevent risk of introduction and spread.

Common adverse reactions (>10%) include localised tissue reactions, ophthalmic discharge and a temporary increase in body temperature up to 2.6°C for one to five days. Loss of appetite and changes in behaviour for one day are common (1-10%).

© 2024 Grovet B.V. All rights reserved.